IRLAB Therapeutics | IRLAB Annual Report & Investor Relations Data
ISIN
SE0012675361
Ticker
IRLAB
Sector
Industry
Country
Sweden
Year Founded
2013
ISIN
SE0012675361
Ticker
IRLAB
Sector
Industry
Country
Sweden
Year Founded
2013
Rooted in Nobel Prize-winning research, IRLAB has grown rapidly to become recognized and respected as a world-leader in understanding the complex neuropharmacology of CNS disorders and especially Parkinson’s disease. We have a well-defined, strategically focused R&D pipeline of powerful new treatments targeting the various stages of Parkinson’s as they worsen over time throughout the patient’s journey of neurodegeneration.
Having a full range of effective disease management options for Parkinson’s patients is regarded as essential by both the medical and patient communities – and at the same time potentially a blockbuster pharmaceutical business.
| Type | Document | Details | Language | Filing Date | File Number |
|---|
Access comprehensive European stock market filings data through a single, powerful API.
1,5M+
filings covered
18
European countries
30min
max latency
1 API
for all filings
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 05.08.2024 | Kristina Torfgård | Other | Buy | SEK 140,850.00 |
| 05.08.2024 | Kristina Torfgård | Other | Buy | SEK 70,875.00 |
| 14.05.2024 | Gunnar Olof Olsson | Other | Buy | SEK 31,000.00 |
| 10.05.2024 | Daniel Johnsson | Other | Buy | SEK 259,680.00 |
| 03.04.2023 | Joakim Tedroff | Other | Buy | SEK 2,038,685.20 |
| 01.09.2022 | Richard Godfrey | Other | Buy | SEK 174,457.00 |
| 30.08.2022 | Viktor Siewertz | Other | Buy | SEK 1,420.00 |
| 29.08.2022 | Viktor Siewertz | Other | Sell | SEK 1,408.00 |
| 15.07.2022 | Joakim Tedroff | Other | Other | SEK 0.00 |
| 31.05.2022 | Viktor Siewertz | Other | Buy | SEK 170,370.00 |
We currently don't have information about the management or supervisory board for this company. This information will be updated as soon as it becomes available.
VSC
Sector
Health Care
Country
Germany
ISIN
DE000A3E5C40
Founded
1997
4SC focuses on the development of novel small molecule drugs that target key mechanisms of cancer development, such as histone …
ABNX
Sector
Health Care
Country
France
ISIN
FR0012616852
Founded
ABIONYX Pharma is a new-generation biotech company that aims to contribute to health through innovative therapies in indications where there …
ABLI
Sector
Health Care
Country
Sweden
ISIN
SE0002575340
Founded
2000
Abliva develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare and often very severe diseases occur when …
AB
Sector
Health Care
Country
France
ISIN
FR0010557264
Founded
2001
AB Science is a late-clinical-stage French company founded in 2001 by a team of scientists with the goal of developing …
ALACT
Sector
Health Care
Country
France
ISIN
FR0014005OJ5
Founded
Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of …
ACTI
Sector
Health Care
Country
Sweden
ISIN
SE0001137985
Founded
1998
Active Biotech develops pharmaceutical products within medical areas where the immune system is of significant importance, including cancer and inflammatory …